ABVC Biopharma (NASDAQ: ABVC) Inks Major Licensing Agreement with Xinnovation Therapeutics for ABV-1504 and ABV-1505 ABVC Biopharma, Inc. has signed an exclusive licensing term sheet with Xinnovation Therapeutics Co., Ltd for the development and distribution of ABV-1504 and ABV-15

You are viewing a robot-friendly page.Click hereto reload in standard format.